News

Back to the list

The Pharmaceutical Market: Creation of Fair Play Rules on the Pharmaceutical Markets of the BRICS and CIS countries

13.03.2015

On 12 March 2015, AEB took part in the Round Table “The Pharmaceutical Market: Creation of Fair Play Rules on the Pharmaceutical Markets of the BRICS and CIS countries”. The event was dedicated to the discussion of the existing antitrust problems on the pharmaceutical market which is regarded as one of the most complex multilateral markets. The Round Table took place in the Federal Antimonopoly Service (FAS) of the Russian Federation and was opened by Igor Artemiev, Head of the FAS. 


Frank Schauff, AEB CEO, and Sergey Smirnov, Chairman of the AEB Health and Pharmaceuticals Committee, Chairman of the Board of OOO “Novo Nordisk”, made the first public presentation of the concept of the Code of Conduct for pharmaceutical producers. The Code is drafted by a special Working Group which was established within the AEB Health and Pharma Committee in November 2014 and is in a regular dialogue with the FAS Russia. The Code takes into account the previous successful experience of the AEB Automobile Manufacturers Committee. It will be open to any pharmaceutical producer and is expected to be published by June 2015.

Frank Schauff, AEB CEO



Share: